Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Napredno
  • The Prolyl Hydroxylase Inhibit...
  • Citiraj
  • Pošljite SMS
  • Pošljite email
  • Natisni
  • Izvozi zadetek
    • Izvozi v RefWorks
    • Izvozi v EndNoteWeb
    • Izvozi v EndNote
  • Permanent link
The Prolyl Hydroxylase Inhibitor BIQ/FG-2216 Stabilises HIF-1 alpha and Upregulates VEGF in vitro: A Potential Strategy For Difficult CTO Lesions in Patients.

The Prolyl Hydroxylase Inhibitor BIQ/FG-2216 Stabilises HIF-1 alpha and Upregulates VEGF in vitro: A Potential Strategy For Difficult CTO Lesions in Patients.

Bibliografske podrobnosti
Main Authors: Barnett, G, Flashman, E, Kelly, D, Schofield, C, Gershlick, A
Format: Conference item
Izdano: 2013
  • Zaloga
  • Opis
  • Podobne knjige/članki
  • Knjižničarski pogled

Podobne knjige/članki

  • 74 Pro-Angiogenic Effects of the Prolyl-hydroxylase Inhibitor FG-2216/BIQ: Therapeutic Angiogenesis for the Treatment of Chronic Total Occlusions.
    od: Barnett, G, et al.
    Izdano: (2014)
  • Pro-angiogenic effects of proly-hydroxylase inhibitor FG-2216 and potential for use in a novel strategy of therapeutic angiogenesis for difficult cases of coronary total occlusion
    od: Barnett, G, et al.
    Izdano: (2014)
  • Enhanced Endothelial Tubule Formation in Response to Proly-Hydroxylase Inhibitor FG-2216: A Step Towards Therapeutic Angiogenesis in Chronic Total Occlusions
    od: Barnett, G, et al.
    Izdano: (2012)
  • Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
    od: Flashman, E, et al.
    Izdano: (2010)
  • Regulation of HIF: prolyl hydroxylases.
    od: Stolze, I, et al.
    Izdano: (2006)

Iskalne možnosti

  • Iskalna zgodovina
  • Napredno iskanje

Poišči več

  • Prelistaj katalog
  • Po abecedi
  • Explore Channels
  • Obvezna literatura
  • Novi knjige/članki

Potrebujete pomoč?

  • Navodila za iskanje
  • Vprašaj knjižničarja
  • Pogosta vprašanja